16:20 EDT Emergent BioSolutions (EBS) files $250M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Apple invests extra $100B in U.S., Trump wants Intel CEO to resign: Morning Buzz
- Emergent BioSolutions reports Q2 adjusted EPS 16c vs ($2.32) last year
- Emergent BioSolutions narrows FY25 revenue to $765M-$835M from $750M-$850M
- Emergent BioSolutions sees Q3 revenue $180M-$210M, consensus $212.7M
- Emergent BioSolutions Reports Improved Q2 2025 Results